Case Reports

Azacitidine-induced remission enables allogeneic transplantation in TET2/BCOR-mutant relapsed extranodal natural killer/T-cell lymphoma: a case report

Oncology Department, Geneva University Hospitals, 1205 Geneva
Department of Clinical Neurosciences, Geneva University Hospitals, 1205 Geneva
Oncology Department, Geneva University Hospitals, 1205 Geneva
Oncology Department, Geneva University Hospitals, 1205 Geneva
Division of Nuclear Medicine and Molecular Imaging, Geneva University Hospitals, 1205 Geneva
Oncology Department, Geneva University Hospitals, 1205 Geneva
Division of Clinical Pathology, Geneva University Hospital, 1205 Geneva
Lymphoid Hematology Department, Henri Mondor University Hospital, AP-HP, and Paris-Est Créteil University, Créteil
Department Hematology, Hôpital Necker, Assistance Publique Hôpitaux de Paris, University Paris Descartes, Imagine Institute, INSERM U1123, Paris
Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA
Division of Clinical Pathology, Geneva University Hospital, 1205 Geneva
Oncology Department, Geneva University Hospitals, 1205 Geneva, Switzerland; Centre for Translational Research in Onco-Hematology, Faculty of Medicine, University of Geneva, and Swiss Cancer Centre Leman, 1206 Geneva
Haematologica Early view Apr 2, 2026 https://doi.org/10.3324/haematol.2025.300314